Understanding & Conquering Depression

KEYPOINTS

• 01

  Major depression is common, disabling and different from feeling down

  Huberman separates major (unipolar) depression from bipolar depression, which gets its own episode. Major depression affects about 5% of people and is the fourth leading cause of disability. Signs include grief, a newly low threshold for crying, guilt and anhedonia, where food, sex, exercise and socializing feel flat. He urges listeners to take any warning signs to a professional rather than diagnose themselves.

• 02

  'Anti-self confabulation' distorts how depressed people see their own progress

  Like a person with dementia inventing stories about where they've been, a depressed person may tell themselves stories in which they are failing despite clear evidence otherwise. His example is an injured athlete who insists they are getting weaker while their physical therapist sees real improvement. The athlete explains it away by saying the parking lot was rearranged.

• 03

  Depression also shows up in the body, in sleep and in cortisol

  So-called vegetative symptoms run below conscious thought: constant exhaustion, waking at 3–5 a.m. and being unable to fall back asleep, disrupted sleep structure (slow-wave sleep normally comes before REM), and reduced appetite. One physiological signature is a cortisol peak that shifts from morning to around 9 p.m.

• 04

  Three neuromodulators map onto different symptoms

  He links low norepinephrine to lethargy and slowed movement, low dopamine to lack of motivation, and low serotonin to grief and shame. Drugs that mainly boost dopamine and norepinephrine avoid serotonin side effects but can cause anxiety or be habit-forming. Emotional and physical pain overlap through substance P, and substance P inhibitors have helped some depressed patients.

• 05

  SSRIs make serotonin work better but do not create more of it

  By blocking reuptake, drugs such as fluoxetine leave serotonin in the synapse longer. About two-thirds of people get some or full relief, while roughly one-third get none. The two-week delay before benefits appear suggests the drugs work through plasticity, either by forming new neurons in the hippocampus's dentate gyrus or by reopening critical periods, as Lamberto Maffei's group in Pisa showed in animals.

• 06

  Hormones and repeated stress raise the risk

  About 20% of people with major depression have low thyroid hormone, and psychiatrists sometimes prescribe thyroid medication. Childbirth, certain phases of the menstrual cycle and menopause also raise risk, so he suggests a blood panel that includes thyroid and cortisol. Risk climbs with each long bout of stress, especially after four to five, often surfacing months after a breakup or a hard stretch at school or work.

• 07

  Genes such as 5-HTTLPR make depression more likely after stress, but don't guarantee it

  Large studies, starting in New Zealand, found that people with certain versions of the serotonin-transporter gene 5-HTTLPR can become depressed after one or two major stressors instead of four or five. That makes learning to manage stress especially important for anyone with a family history.

• 08

  Inflammation diverts tryptophan away from serotonin

  Chronic stress raises inflammatory signals such as IL-6, TNF-alpha and CRP. These push the enzyme IDO to turn dietary tryptophan into kynurenine and then into quinolinic acid, which damages neurons and promotes depression. Lowering inflammation lets more tryptophan become serotonin. He suggests the late-night carb cravings common in depression may be an attempt to get more tryptophan.

• 09

  Ketamine and psilocybin both seem to act through plasticity in cortical layer 5

  Ketamine blocks the NMDA receptor, which puzzles him because NMDA activation normally drives plasticity. Yet a 2019 Science paper with Liston as senior author showed ketamine relieves symptoms by growing dendritic spines in the prefrontal cortex. Psilocybin acts at serotonin 5-HT2A receptors and may broaden lateral connections in layer 5. Ketamine works by distancing people from their experience, while psilocybin works by immersing them in it.